Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert M Verleden

Showing results (151-160 of 264) with videos related to

Pageof 27
Sort By:
ERJ Open Research|July 28, 2022
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directionsAllan R Glanville, Christian Benden, Anne Bergeron, et al.
Clinical Transplantation|January 21, 2020
Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center studyStijn E Verleden, Jan Von Der Thüsen, Anke Van Herck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 14, 2011
Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donorsStéphanie I De Vleeschauwer, Shana Wauters, Lieven J Dupont, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Obliterative bronchiolitis following lung transplantation: from old to new concepts?Geert M Verleden, Robin Vos, Stéphanie I De Vleeschauwer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 26, 2008
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injuryNele Geudens, Lien Timmermans, Hadewijch Vanhooren, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2016
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialKristina Vermeersch, Maria Gabrovska, Griet Deslypere, et al.
The European Respiratory Journal|August 24, 2019
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunctionAnnelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 2011
Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavageStijn E Verleden, Robin Vos, Veerle Mertens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 19, 2013
Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patientsStijn E Verleden, Robin Vos, Elly Vandermeulen, et al.
Transplantation|July 23, 2014
Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunctionStijn E Verleden, David Ruttens, Robin Vos, et al.
Pageof 27

Showing results (151-160 of 264) with videos related to

Sort By:
Pageof 27
ERJ Open Research|July 28, 2022
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directionsAllan R Glanville, Christian Benden, Anne Bergeron, et al.
Clinical Transplantation|January 21, 2020
Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center studyStijn E Verleden, Jan Von Der Thüsen, Anke Van Herck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 14, 2011
Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donorsStéphanie I De Vleeschauwer, Shana Wauters, Lieven J Dupont, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Obliterative bronchiolitis following lung transplantation: from old to new concepts?Geert M Verleden, Robin Vos, Stéphanie I De Vleeschauwer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 26, 2008
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injuryNele Geudens, Lien Timmermans, Hadewijch Vanhooren, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2016
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialKristina Vermeersch, Maria Gabrovska, Griet Deslypere, et al.
The European Respiratory Journal|August 24, 2019
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunctionAnnelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 1, 2011
Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavageStijn E Verleden, Robin Vos, Veerle Mertens, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 19, 2013
Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patientsStijn E Verleden, Robin Vos, Elly Vandermeulen, et al.
Transplantation|July 23, 2014
Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunctionStijn E Verleden, David Ruttens, Robin Vos, et al.
Pageof 27